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Background: A neuropathogenic variant of Friend murine leukemia virus (Fr-MLV) clone A8 induces spongiform
neurodegeneration when infected into neonatal rats. Studies with chimeras constructed from the A8 virus and the
non-neuropathogenic Fr-MLV clone 57 identified a 0.3-kb KpnI-AatII fragment containing a R-U5-5’leader sequence
as an important determinant for inducing spongiosis, in addition to the env gene of A8 as the primary determinant.
This 0.3-kb fragment contains a 17-nucleotide difference between the A8 and 57 sequences. We previously showed
that the 0.3-kb fragment influences expression levels of Env protein in both cultured cells and rat brain, but the
corresponding molecular mechanisms are not well understood.
Results: Studies with expression vectors constructed from the full-length proviral genome of Fr-MLV that
incorporated the luciferase (luc) gene instead of the env gene found that the vector containing the A8-0.3-kb
fragment yielded a larger amount of spliced luc-mRNA and showed higher expression of luciferase when compared
to the vector containing the 57-0.3-kb fragment. The amount of total transcripts from the vectors, the poly (A) tail
length of their mRNAs, and the nuclear-cytoplasm distribution of luc-mRNA in transfected cells were also evaluated.
The 0.3-kb fragment did not influence transcription efficiency, mRNA polyadenylation or nuclear export of luc-mRNA.
Mutational analyses were carried out to determine the importance of nucleotides that differ between the A8 and
57 sequences within the 0.3-kb fragment. In particular, seven nucleotides upstream of the 5’splice site (5’ss) were
found to be important in regulating the level of protein expression from spliced messages. Interestingly, these
nucleotides reside within the stem-loop structure that has been speculated to limit the recognition of 5’ss.
Conclusions: The 0.3-kb fragment containing the R-U5-5’leader sequence of Fr-MLV influences the level of protein
expression from the spliced-mRNA by regulating the splicing efficiency rather than transcription, nuclear export of
spliced-mRNA, or poly (A) addition to mRNA. Seven nucleotides in the 0.3-kb fragment, which reside within the
stem-loop structure that has been speculated to limit recognition of the 5’ss, could pinpoint the function of this
region.
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The simple retroviruses, including MLV, are characte-
rized by a coding structure in which the gag, pol and env
genes are flanked by two long terminal repeats (LTRs), a
5’LTR and 3’LTR. Proteins responsible for the constitu-
tion of the inner structures of the virion are encoded by
the gag gene, which includes the matrix, capsid and nu-
cleocapsid proteins. The pol gene encodes the enzymatic
proteins, i.e. the reverse transcriptase, protease, integrase
and RNase H and the env gene encodes the proteins
protruding out from the viral particle surface, namely
the surface (SU) and transmembrane (TM) proteins [1].
Transcription begins from the R region of the 5’LTR and
ends at the polyadenylation signal located at the R re-
gion at the other end of the 3’LTR. A 5’ss is located in
the 5’leader sequence and a 3’splice site (3’ss) is located
at the 3’ end of the pol gene. Only a singly spliced
mRNA is usually found in simple retroviruses. Gag and
Pol proteins are translated from the unspliced full-length
viral mRNA, and the Env protein is translated from the
spliced env-mRNA [1]. In contrast, it has been reported
that human immunodeficiency virus (HIV) type 1, which
is a complex retrovirus, could generate up to 40 different
spliced RNAs using four 5’ss and nine 3’ss [2-4].
A neuropathogenic variant of Fr-MLV, clone A8, in-
duces spongiform neurodegeneration in neonatal rats.
Studies with chimeras constructed from the A8 virus
and the non-neuropathogenic Fr-MLV clone 57 identi-
fied a 0.3-kb KpnI-AatII fragment containing the R-U5-
5’leader sequence as an important determinant of
neuropathogenicity, in addition to the env gene of A8 as
the primary determinant [5]. The A8-Env protein ex-
pression level is also correlated with neuropathogenicity
[5,6]. Chimeric virus Rec5, which contains the A8-env
gene on the background of 57, did not exhibit
neuropathogenicity. In contrast, the chimeric virus R7f,
which contains a 0.3-kb fragment of A8 and the A8-env
gene on the background of 57, induced spongiform
neurodegeneration. It has been shown that the expres-
sion level of Env protein in both R7f-infected cultured
cells and in brains of R7f-infected rats was higher than
in the Rec5-infected cultured cells and brains of Rec5-
infected rats [5,6]. These findings suggested that the
0.3-kb fragment influences Env protein expression.
However the steps of gene expression at which the
0.3-kb fragment may influence Env expression have yet
to be elucidated.
Given that the 0.3-kb fragment containing the R-U5-
5’leader sequence is the first untranslated region that
exists in all variants of retroviral transcripts, this region
dynamically impacts various stages of the viral life cycle.
The R region, present at both ends of viral RNA, medi-
ates the jump of reverse transcriptase from the 5’ site to
the 3’ site during the synthesis of minus-strand DNA[7,8], possibly by mediating genome circularization
[9-11]. In addition, the stem-loop structure of the R
region is important for transcriptional activity and
enhances gene expression of a variety of retroviruses,
including HIV, human T cell leukemia virus, bovine
leukemia virus, avian reticuloendotheliosis virus, MLV,
mouse mammary tumor virus, human foamy virus, and
spleen necrosis virus [12-24]. The end of the U5 region
is marked by the beginning of the primer binding site
(PBS) for reverse transcription [25-27]. The surrounding
region of U5 with the 5’leader sequence (which extends
from the PBS to the AUG codon of gag) has specific
sequences with distinct secondary structure features
[28,29]. There is strong evidence that this region is ro-
bust and that the secondary structures presented are
fine-tuned to regulate one stage of RNA processes, and
they could also act as inhibitors for other processes [30].
For example, the stem loop of DIS-1 (dimer initiation
site-1), which plays a role in initiating viral RNA dimer
formation, is situated immediately downstream of the
5’ss. By deleting this stem loop structure, the splicing ef-
ficiency of a modified Akv-MLV increased 5–10 fold,
illustrating the modulating effect of DIS-1 on the pro-
duction of viral genomes [31]. Interestingly, sequences
upstream of 5’ss have also been reported to be limiting
factors for splicing regulation [32]. A secondary struc-
ture known as the B monomer was presented in Mougel
et al. [28] and is a discerning trait in the MLV. This sec-
ondary structure, which is adopted in the dimeric RNA
form, has also been shown to limit the recognition of
U1snRNA to the splice donor, thereby also regulating
the viral RNA production volume. Finally, the highly
dynamic encapsidation structure that has been studied
extensively in the prototype of MLV, Moloney MLV
(Mo-MLV) [33-35], is important for dimerization of the
genomic RNA [36,37]. It includes an IRES (internal ribo-
somal entry segment) [38,39] and also functions in the
transport of viral intron-containing RNAs from the
nucleus to the cytoplasm [34,40].
In this study, to investigate the role of the 0.3-kb frag-
ment containing the R-U5-5’leader sequence in the
expression of Env protein of Fr-MLV, we constructed
expression vectors having the full-length proviral gen-
ome of Fr-MLV with the luciferase (luc) gene incorpo-
rated in place of the env gene. We then examined the
effects of the 0.3-kb fragment on several steps affecting
protein expression levels in NIH3T3 cells. The results
showed that the 0.3-kb fragment of A8 enhanced protein
expression levels from the spliced mRNA through up-
regulating the efficiency of splicing compared with the
0.3-kb fragment of 57, rather than through increased
transcription, poly (A) addition to mRNA, or nuclear ex-
port of spliced mRNA. Furthermore, we investigated
more specifically the roles of the nucleotides that differ
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of the 0.3-kb fragment. Lastly, we discuss the possible
mechanism by which the 0.3-kb fragment participates in
protein expression.
Results
The 0.3-kb fragment effects on luciferase protein
expression and the amount of spliced luc-mRNA
This study is based on a background study which
revealed that the 0.3-kb KpnI-AatII fragment containing
the R-U5-5’leader sequence was essential for the induc-
tion of spongiform neurodegeneration and for up-
regulation of Env protein expression [5]. The purpose of
the present study is to further investigate the function of
the 0.3-kb fragment in retroviral gene expression. Be-
tween the A8 and 57 sequences within the 0.3-kb frag-
ment, 17 nucleotides differ (Figure 1). In our previous
study, neuropathogenic R7f, which contains the A8-0.3-kb
fragment and the A8-env gene on the background of
57, was shown to increase Env expression about 3-fold
compared to non-neuropathogenic Rec5, which contains
the 57-0.3-kb fragment and the A8-env gene on theFigure 1 Alignment of the 0.3-kb KpnI-AatII fragment of A8 [accessio
the sequence identity. PolyA: polyadenylation signal; PBS: primer binding site;
protein. Nucleotides that differ between A8 and 57 within the 0.3-kb fragmenbackground of 57 [5,6]. To investigate the function of
the 0.3-kb fragment in viral gene expression, the full-
length viral genomes of Rec5 and R7f were recombined
with the luc gene, in which the viral env gene was
replaced with the luc gene to produce the lucifer-
ase expression vectors Rec5-L and R7f-L, respectively
(Figure 2A). Both Rec5-L and R7f-L were constructed
using the complete virus 57 sequences, however, in R7f-L
the 0.3-kb fragment was derived from the viral A8 se-
quence. The luciferase protein is translated from spliced
mRNA of these expression vectors. After transfection of
the vectors into NIH3T3 cells, luciferase activities were
measured. The luciferase activity of R7f-L increased by
2-fold compared to that of Rec5-L (p < 0.001) (Figure 2B).
To determine the role of the 0.3-kb fragment positioned
at the 5’LTR-leader sequence and the 3’LTR in the ex-
pression vectors, R7fa-L and R7fb-L were constructed
(Figure 2A). R7fa-L, which carries the 0.3-kb fragment
of A8 only at the 5’LTR-leader sequence, exhibited the
same amount of luciferase activity as R7f-L, and the lu-
ciferase activity of R7fb-L, which carries the 0.3-kb frag-
ment of A8 only at the 3’LTR, showed luciferase activityn no. D88386] and 57 [accession no. X02794]. Asterisks represent
5’ss: 5’ splice site; glyco-Gag start; the start codon of glycosylated-Gag
t are numbered.
Figure 2 (See legend on next page.)
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Figure 2 Structures of luciferase expression vectors (A). In the viral genomes, solid regions are sequences derived from the A8 virus and
open regions are sequence derived from the 57 virus. The numbering of nucleotides is based on the transcript. Vectors, primers and probes used
to detect the corresponding mRNA by RT-PCR are indicated on the vectors. 5’ss: 5’splice site; 3’ss: 3’splice site. Relative Luciferase activity (B) and
relative amount of spliced luc-mRNA and total mRNA (C). The graphs show the mean values from 4–7 independent results and the SEM are
indicated as half whiskers. The statistical comparison was carried out using the t test.
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parable to that of Rec5-L (Figure 2B).
Furthermore, the effect of the 0.3-kb fragment on the
luc-mRNA level was also determined. The spliced luc-
mRNA levels were measured by real-time RT-PCR using
s6 and s2 primers (Figure 2A). These primers were
designed to amplify a fragment containing the splicing
junction region from the cDNA of spliced transcripts.
The amount of spliced luc-mRNA from R7f-L increased
by 2-fold compared to that from Rec5-L (p < 0.001)
(Figure 2C). The amount of spliced luc-mRNA from
R7fa-L was the same as that from R7f-L. The amount of
spliced luc-mRNA from R7fb-L was lower than that
from R7fa-L (p < 0.01) but was comparable with that
from Rec5-L (Figure 2C). The amount of spliced mRNAs
paralleled the luciferase activity. Next, to examine effects
of the 0.3-kb fragment on transcriptional activity, the
amount of total transcripts from expression vectors were
measured by real-time RT-PCR using the LucF and LucR
primers (Figure 2A). The amounts of total mRNA mea-
sured for all of the expression vectors were comparable
(Figure 2C).
The 0.3-kb fragment did not affect the poly (A) tail length of
mRNA or the nuclear-cytoplasmic distribution of luc-mRNA
In general, the poly (A) tail length of mRNA is corre-
lated with the efficiency of translation. Therefore, to
examine whether or not the 0.3-kb fragment influencesFigure 3 Determination of poly (A) tail length. Total RNAs extracted fro
primer RVP3 oligo. First strand cDNA synthesis was carried with an antisens
transcripts derived from Rec5-L and R7f-L were then selectively amplified u
reverse primer for the RVP3 sequence. To confirm that the first strand of cD
spliced luciferase-mRNA, PCR was performed using the primer set of f-597
gapdh-mRNA were detected in Rec5-L and R7f-L transfected cells. The PCR
staining.polyadenylation of viral mRNA, the poly (A) tail lengths
of mRNA from Rec5-L and R7f-L transfected Hela cells
were compared. Total RNA was harvested and anchored
with the RVP3 primer before the first strand of cDNA
was synthesized with an anti-RVP3 oligo strand. To
determine the poly (A) tail length, the transcripts de-
rived from Rec5-L and R7f-L were selectively amplified
using the forward primer for viral U3 sequences of the
3’LTR and the reverse primer for the RVP3 sequence.
PCR products viewed on electrophoresed gels showed
no detectable differences in the smeared patterns indi-
cating the poly (A) tail lengths of transcripts derived
from R7f-L and Rec5-L (Figure 3). In this system, the
poly (A) tail lengths of transcripts containing both the
unspliced mRNA and the spliced mRNA derived from
the vectors could be detected. Therefore, to confirm that
the first strand of cDNA synthesized with an anti-RVP3
oligo strand contained spliced-mRNA, from which lucif-
erase protein was translated, PCR was performed using
the primer set of f-597 and s2. As shown in Figure 3, a
113-bp band that came from spliced-mRNA was
detected in both Rec5-L and R7f-L transfected cells. As
a control, the poly (A) tail length of gapdh-mRNA was
examined in Rec5-L and R7f-L transfected cells. In both
of these cells, a 177-bp band for gapdh-mRNA was
detected, and there were no detectable differences in the
smeared patterns indicating the poly (A) tail length of
gapdh-mRNA (Figure 3).m 24 hours post-transfected Hela-cells were ligated with the anchor
e sequence to the anchor primer. To detect poly (A) tail length, the
sing the forward primer for viral U3 sequences of the 3’ LTR and the
NA that was synthesized with an anti-RVP3 oligo strand contained
and s2. As a control, the gapdh-mRNA and poly (A) tail length of
products were electrophoresed and visualized by ethidium-bromide
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influenced the amount of spliced messages and subse-
quently the expression of its corresponding luciferase
protein, we set out to determine the nuclear-cytoplasmic
distribution of the spliced message. NIH3T3 cells
transfected with Rec5-L and R7f-L vectors were di-
vided into nuclear and cytoplasmic fractions and total
RNA was extracted from each fraction. The separation
of nucleus and cytoplasm was confirmed by assaying
for the presence of ribosomal RNAs. The mature 18S
and 28S ribosomal RNAs were detected predominantly
in the cytoplasmic fraction (data not shown). In the
cells transfected with Rec5-L, 12% of luc-mRNA was
detected in the cytoplasmic fraction and 88% was in
the nuclear fraction (Figure 4). In the cells transfected
with R7f-L, 17% of luc-mRNA was detected in the
cytoplasmic fraction and 83% was in the nuclear frac-
tion. In both types of cell, gapdh-mRNA was predo-
minantly in the cytoplasmic fraction, with 59% (Rec5-L)
and 65% (R7f-L) of the gapdh-mRNA in the cytoplasm and
about 41% (Rec5-L) and 35% (R7f-L) remaining in the nu-
cleus (Figure 4). The distribution of luc-mRNA in the nu-
cleus and cytoplasm of the cells with introduced Rec5-L
and R7f-L was not significantly different.
Point mutation analysis
Further investigations were carried out to determine
whether any of the nucleotides within the 0.3-kb frag-
ment are key(s) to the observed luciferase expression
effects. Using the same luciferase expression vectors, a
series of point mutations was incorporated into the R7f-L
0.3-kb fragment, in which the 17 nucleotides that differ
between the A8 and 57 sequences were gradually mu-
tated into sequences of 57 from the 5’ site. The luci-
ferase activity of these vectors was determined (Figure 5).Figure 4 Nuclear-cytoplasmic distribution of luc-mRNA. Nuclear
and cytoplasmic fractions were obtained from NIH3T3 cells
transfected with R7f-L and Rec5-L and RNA was extracted from each
fraction. The amount of spliced luc-mRNA and gapdh-mRNA in each
fraction was quantified by real-time RT-PCR. The mean values from 3
independent experiments and the SEM are shown. Statistical
comparison was done using the t test.F1-L, which has its first four nucleotides exchanged for 57
sequences, showed results comparable to those obtained
for R7f-L. Interestingly, when further mutations were in-
troduced at the 5th nucleotide in F2-L, the luciferase acti-
vity decreased to 67% (p < 0.001) compared to F1-L. The
luciferase activity of F3-L, in which further mutations were
introduced at the 6th and 7th nucleotides, decreased to
50% and was lower than that of F2-L (p < 0.001). The luci-
ferase activity of F4-L, in which further mutations were in-
troduced at the 8th nucleotide, was the same as that of F3-L.
On the other hand, we constructed the B series vectors in
which mutations were incorporated from the 3’ site of 0.3-kb
fragment. When the 9th to 14th nucleotides were further ex-
changed for their 57 counterparts, the luciferase activity
showed no significant difference compared to R7f-L in B2-L
(101%) and B3-L (87%).
After evaluating the results of experiments with the F
series vectors, we asked if the 5th, 6th and 7th nucleotides
alone could contribute to the regulation of luciferase acti-
vity. Towards this end, we constructed: (a) R7f.567 m-L, in
which only the 5th, 6th and 7th nucleotides contain the 57
sequences and (b) another vector having the exact reverse
order, Rec5.567 m-L, which has only the 5th, 6th and 7th
sequences retained as A8 sequences. The luciferase activity
of R7f.567 m-L remained at about 95% and could not be
brought down to parallel that of Rec5-L, while its exact re-
verse vector, Rec5.567 m-L, had a significantly increased lu-
ciferase activity (86%) that was higher than that of Rec5-L
(p < 0.001).Secondary structure analysis
To explain how the 1st to 7th nucleotides might be im-
portant for luc-mRNA expression, we mapped out the
secondary structure formed by the sequence containing
the 1st to 7th nucleotides of the 0.3-kb fragment of the
A8 and 57 sequences. The secondary structure, as shown
in Figure 6, was predicted using MFOLD software. Ap-
propriate regions were selected where the sequence
should be truncated by referring to previous studies that
had utilized chemical structural probing, NMR, and a
functional analysis of Mo-MLV [28,33,41]. Figure 6 illus-
trates the major functional secondary structures of MLV.
At first glance, there is not a striking difference between
the two secondary structures generated, despite the 7
nucleotides that differ between the A8 and 57 sequences.
The most visible changes actually occur upstream from
the polyadenylation signal, where the 1st, 2nd, and 3rd
nucleotides are incorporated into a stem structure in the
A8 sequence, thereby lengthening the stem structure
compared to the 57 sequence. The site with the smallest
conformational change contains the 5th, 6th and 7th
nucleotides. These three nucleotides reside within a
stem-loop structure that protrudes out into the PBS.
Figure 5 Luciferase activity of mutation series vectors. A series of vectors where the sequences from A8 were gradually mutated into 57
sequences were constructed and their luciferase activities were quantified. Mutations from A8 to 57 are indicated by triangles. The mean values
from 4–7 independent experiments and the SEM are shown. Statistical comparison was done using the t test. ns: differences were not significant.
*: differences were not significant versus R7f-L.
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discussed further in the next section.
Alignment of the 0.3-kb fragment sequences among
gamma retroviruses
Since point mutational analysis indicated the 1st to 7th
nucleotides contribute to the luciferase activities of the
vectors, we compared the sequences including these nu-
cleotides in gamma retroviruses containing MLVs, Feline
leukemia virus (FLV), and Gibbon ape leukemia virus
(GALV) (Table 1). The 1st guanine (G) nucleotide in A8
was well conserved among these gamma retroviruses ex-
cept for 57. The 2nd and 3rd nucleotides in A8 were ad-
enine (A) and thymidine (T), respectively, and the 4th,
5th, and 6th nucleotides in 57 were G, cytosine (C), and
T, respectively. These nucleotides were relatively con-
served among the gamma retroviruses that were ana-
lyzed. The 7th guanine nucleotide in A8 was well
conserved in not only MLVs but also in FLV and the
GALV. Among the sequences analyzed, only the Fr-MLV
clone 57 virus had an adenine at the 7th nucleotide.
Discussion
In the present study, to investigate the role of a 0.3-kb
KpnI-AatII fragment containing the R-U5-5’leader se-
quence, recombinant luciferase vectors were constructed
by replacing the viral-env-gene with the luc-gene in pro-
viral sequences to produce R7f-L and Rec5-L (Figure 2A).
As shown in Figure 2B, R7f-L exhibited about 2 times
higher luciferase expression compared to Rec5-L. This
result agrees well with experiments that utilized the
chimeric viruses R7f and Rec5, in which the Env protein
expression level of R7f-infected cells was higher than
that of Rec5-infected cells [5]. Therefore, the experimen-
tal system using R7f-L and Rec5-L vectors is useful to
analyze the function of the 0.3-kb fragment in Envprotein expression. Next, to examine whether the 0.3-kb
fragment functions in the 5’LTR-leader sequence and/or
in the 3’LTR, we constructed R7fa-L and R7fb-L. R7fa-L
contains the 0.3-kb fragment of A8 sequences only at
the 5’LTR, and R7fb-L contains the 57 sequences at the
5’LTR but has the A8 sequences of the R-U5 region at
the 3’LTR (Figure 2A). The results of a luciferase assay
showed that R7fa-L mimics the expression level of R7f-L
(Figure 2B). R7fb-L, despite having partial A8 sequences
at its 3’LTR, had a similarly reduced expression level of
Rec5-L. These results suggested that luciferase expres-
sion is dependent solely on the 0.3-kb sequences at the
5’LTR-leader sequence rather than the sequences at the
3’LTR.
In the luciferase expression vector system of the
present study, luciferase protein is translated from
spliced mRNA. When quantified in transfected cells, the
amount of spliced luc-mRNA in the cells transfected
with R7f-L was about 2 times higher than that in the
cells transfected with Rec5-L (Figure 2C). Furthermore,
the amount of spliced luc-mRNA of R7fa-L was equiva-
lent to the amount of spliced luc-mRNA of R7f-L, and
R7fb-L showed the same amount of spliced luc-mRNA
as Rec5-L (Figure 2C). The amount of spliced transcripts
from the vectors correlated with the luciferase activities
(Figure 2B). These results indicated that the 0.3-kb frag-
ment of A8 enhanced luciferase expression levels by in-
creasing the amount of spliced luc-mRNA. This raised
the question of how the 0.3-kb fragment of A8 enhanced
the amount of spliced luc-mRNA. Because the amount
of total transcripts, including unspliced mRNA and
spliced mRNA, was the same among Rec5-L, R7f-L,
R7fa-L, and R7fb-L (Figure 2B), the 0.3-kb fragment
seems to not affect the transcriptional step. Other steps
in the maturation of transcripts were also investigated,
e.g. the poly (A) tail length and the nuclear export of
Figure 6 Predicted secondary structure formed by the sequence containing the 1st to 7th nucleotides of the 0.3-kb fragment of the
A8 sequence [accession no. D88386] and the 57 sequence [accession no. X02794]. This representation shows the results of an MFOLD
simulation on the basis of previous studies [28,33,41], and the figure was drawn using VARNA software [42]. Nucleotides that differ between A8
and 57 are shown in red and numbered from 1 to 7. Important regulatory signals are highlighted. PolyA: polyadenylation signal; PBS: primer binding site;
5’ss: 5’splice site. Restriction enzyme KpnI site is also shown.
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differences between the poly (A) tail length of mRNA in
the R7f-L versus the Rec5-L transfected cells (Figure 3).
The nuclear-cytoplasmic distribution of spliced luc-
mRNA was the same for the R7f-L and the Rec5-L
transfected cells (Figure 4), indicating that the efficiency
of nuclear export of spliced luc-mRNA was the same for
both R7f-L and Rec5-L. These results suggest that the
0.3-kb fragment contributes to the splicing efficiency of
transcripts and that luciferase expression is enhanced by
the role of the 0.3-kb fragment of A8 in promoting spli-
cing. As shown in Figure 3, the poly (A) tail length of
viral mRNA was longer than that of gapdh-mRNA. The
reason for this phenomenon is not clear, but release ofpoly (A) polymerase from viral mRNA might be sup-
pressed. The nuclear-cytoplasmic distribution of mRNA
also differs between viral mRNA and gapdh-mRNA. It is
generally known that nuclear export of mRNA is mediated
by multiple protein factors that couple steps of nuclear
pre-mRNA biogenesis to mRNA transport [43] therefore,
different factors might be recruited in viral mRNA com-
pared to gapdh-mRNA.
Next, to investigate the roles of nucleotides that differ
between A8 and 57 within the 0.3-kb fragment, we
gradually mutated the 17 nucleotides that differ between
them and tested their respective luciferase activities.
Among the vectors investigated, only the F3-L, which
carries the 1st to 7th nucleotides of 57 on the
Table 1 Alignment of the 0.3-kb fragment sequences among the gamma retroviruses
Name Accession no. 1st, 2nd, 3rd, 4th nucleotide 5th nucleotide 6th nucleotide 7th nucelotide
Murine leukemia virus
Exogenous ecotropic
Friend clone A8 D88386 CCCGTGTATCCAATAAATCCTCTT CGACTTGTGGT GGATCCGGAGA GCCCAGGGACC
Friend clone 57 X02794 *****A*TC********G****** *****C***** *****T***** *****A*****
Friend FB29 NC_001362 ************************ *****C***** *****T***** ***********
Friend PVC211 M93134 ************************ *********** *********** ***********
Moloney NC_001501 *****************C****** *********** *****G***** ***********
Moloney ts1-92b AF462057 *****************C****** ***A*C***** ****TT***** ***********
Cas-Br-E X57540 *****************C****** *****G***** ********G** *******A***
SRS19-6 AF019230 *******T*********G****** *********** *********** ***********
SL3-3 AF169256 *****************G***T** ***A*C***** *****T***** ***********
RadLV K03363 *****************G***T** ***A*C***** ****TT***** ***********
Rauscher NC_001819 ************************ *********** *****T***** ***********
Graffi GV-1.2 AB187565 *****TCC*–******G****** ***A*C****A *********** ***********
Amphotropic
1313 AF411814 *****************C****** ****GA***** ****TT***** ***********
Xenotropic
DG-75 AF221065 *******TC********G****** ***A*C***** A***TA***** ***********
NZB-9-1 K02730 *******TC********G***T** ***A*C***** *********** ***********
Endogenous ecotoropic
AKV J01998 *****************G***T** ***A*C***** ****TT***** ***********
pSR3 M87550 *****************G***T** ***A*C***** *****T***** ***********
BM5eco AY252102 *****************G***T** ***A*C***** ****TT***** ***********
Polytropic
MCF1233 U13766 *******TC********G***T** ***AAC****C ****TT***** ***********
Unclassified
Abelson NC_001499 *****************C****** *********** *****G***** ***********
Feline leukemia virus NC_001940 ********CG-******C*-**** T****C***** *****GA**CC C***C******
Gibbon ape leukemia virus NC_001885 *******G*********A****** G**GCC***** *****G*A*AC C*–*******
Alignment of sequences around the 1st to 7th nucleotides (underlined). Asterisks represent sequence identities.
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luciferase activity that paralleled that of Rec5-L, which
has the 57 sequence (Figure 5). Furthermore, R7f.567
m-L, which has only the 5th, 6th and 7th sequences
retained as 57 sequences, showed luciferase activity that
remained at about 95% and could not be brought down
to parallel that of Rec5-L. These results suggested that
the 1st to 7th nucleotide of the 0.3-kb fragment were
important regulators of the luciferase protein expression
level.
To illustrate how the 1st to 7th nucleotides of the 0.3-kb
fragment may be functionally important, a secondary
structure was drawn for the fragment containing the 1st to
7th nucleotides of the A8 and 57 sequences, as shown
in Figure 6. The 5th, 6th and 7th nucleotides, which muta-
tional analysis had shown were primary contributors toincreased luciferase expression, reside within a stem-
loop structure that protrudes out into the PBS. It was
previously reported that sequences upstream of the 5’ss
negatively regulate the splicing of MLV by forming a
secondary structure [32]. Kraunus et al. argue that the
stem structure plays a role upstream of the 5’ss in de-
termining the accessibility for cellular splice regulators.
According to Zychlinski et al., the stem structure or re-
gion surrounding the 5’ss regulates the splice donor to
be accessed by U1snRNA, thereby regulating MLV
splicing [44]. The stability and integrity of the stem-loop
structure containing PBS is important to determine the
splicing efficiency: higher stability of the stem-loop
structure seems to inhibit splicing more efficiently. Simi-
larly, in HIV type 1, it has been reported that the stable
hairpin-structure of RNA containing the major 5’ss
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shown in Figure 6, the 4th to 7th nucleotides take part
in the formation of secondary structure around the 5’ss.
Because the secondary structure formed by A8 releases
free energy of dG = −72.5 kcal/mol, while 57 releases
dG= −75.1 kcal/mol, the stem structure of the 57
sequence is likely more stable than the A8 sequence.
This suggests that the stem structure of the 57 se-
quence inhibits splicing more efficiently than the stem
structure of the A8 sequence, resulting in decreased lu-
ciferase activity. Kraunus et al. have studied the
AGGGA motif in the stem structure, which is a poten-
tial binding motif for hnRNPA1, a splice repressor. The
results of experiments in which the AGGGA motif was
mutated have shown that this sequence contributes to
splicing efficiency through altering the secondary struc-
ture stability rather than the sequence motif. The
AGGGA motif in the A8 sequence is also found around
the 7th nucleotide, as shown by arrowheads in Figure 6.
This motif may be demolished by changing the A8-G
sequence at the 7th nucleotide of 57 to adenine, which
may decrease the binding of hnRNPA1, the splice re-
pressor; however, contrary to expectations, luciferase ex-
pression was decreased. In examining the secondary
structure, the base corresponding to the 7th G on the
ascending side of the stem is U in the A8 sequence,
while the base corresponding to the 7th A on the as-
cending side of the stem is U in the 57 sequence
(Figure 6, boxed motif). Kraunus et al. reported that the
higher complementarity of bases facing each other in
the boxed motif decreased the splicing efficiency. This
suggests that the 7th nucleotide plays an important role
in luciferase expression by participating in the splicing
step. Alignment of the gamma retroviral 0.3-kb fragment
sequences showed that the A8-guanine at the 7th position
is conserved among the FLV, GALV, and MLV sequences
except for 57, while the A8-thymine and A8-cytosine at
the 5th and 6th positions, respectively, are less conserved.
The 7th nucleotide is likely to be important for gene ex-
pression of gamma retroviruses, which might explain the
different activities of the 0.3-kb fragments of A8 and 57.
The roles of the 1st to 4th nucleotides are not yet known,
but a change of secondary structure between A8 and 57
has been observed (Figure 6) and this stem loop structure
may also contribute to luciferase expression through ter-
tiary interactions with the stem loop structure formed by
the sequence containing the 5th to 7th nucleotides.
Conclusion
In summary, we have described the role of the 0.3-kb
fragment containing the R-U5-5’leader sequence of
Fr-MLV in gene expression. The 0.3-kb fragment
influenced the protein expression level from spliced-
mRNA by regulating the efficiency of splicing, ratherthan transcription, poly (A) addition to mRNA, or nu-
clear export of spliced-mRNA. Furthermore, seven
nucleotides that apparently contribute to regulation of
gene expression have been identified. Interestingly,
these nucleotides reside within the stem-loop structure




Luciferase expression vectors R7f-L and Rec5-L were
constructed as described previously by replacing the
viral env gene with the luc gene [46] within its proviral
sequences [5]. The point mutations G to T (2608nt), G
to T (2614nt), and G to T (2629nt) were introduced into
the pol gene of each recombinant plasmid. R7fa-L was
constructed by replacing the 57 sequences of KpnI (32)
and AatII (361) with the A8 sequences in Rec5-L. R7fb-L
was generated by replacing the A8 sequences of KpnI
(32) and AatII (361) with the 57 sequences in R7f-L.
Mutation vector F1-L was constructed by mutagenesis
of R7f-L using the following forward primer: CGCCC
GGGTACCCGTATTCCCAATAAAGCCTCTTGCTG;
and the reverse primer: ACGGGTACCCGGGCGAC
TCAGTCTA. F2-L was generated by mutagenesis of
F1-L using the forward primer: TCTTGCTGTTGC
ATCCGACTCGTGGTCTCGCTGTT; and the reverse
primer: AGTCGGATGCAACAGCAAGAGGCTTTAT
TG. F3-L was constructed by mutagenesis of F2-L
using the forward primer: TTTGGGGGCTCGTCC
GGGATCTGGAGACCCTTGCCCAAGGACCACCGA;
and the reverse primer: GATCCCGGACGAGCCC
CCAAATGAAAGACCC. F4-L was generated by muta-
genesis of F3-L using the forward primer: AAGC
TGGCCAGCAATTGATCtGTGTCTGTCC; and the
reverse primer: GATCAATTGCTGGCCAGCTTACC
TCCCGGT. B1-L was generated by mutagenesis of
R7f-L using the forward primer: ACCCGTGGTAG
AACTGACGGGTTCGAGACACCCGGCCGCAA; and
the reverse primer: CGTCAGTTCTACCACGGGT
CCGCCAGATA. B2-L was generated by mutagenesis
of B1-L using the forward primer: TTGGCCG
ACTAGCTCTGTACCTGGCGGACCCGTGGTGGAA
CTGACG; and the reverse primer TACAGAGC
TAGTCGGCCAACTAGTACAGAC. B3-L was gener-
ated by mutagenesis of B2-L using the forward primer:
CCATTGTCCCGTGTCTTTGATTGATTTTATGCGC
CTGCGTTTGTACTAGT; and the reverse primer: TC
AAAGACACGGGACAATGGACAGACACCG. R7f.5 m-L
was constructed by mutagenesis of R7f-L using the forward
primer: TCTTGCTGTTGCATCCGACTCGTGGTCTCG
CTGTT; and the reverse primer: AGTCGGATGCAAC
AGCAAGAGGATTTATTG. R7f.567m-L was constructed
by mutagenesis of R7f.5m-L using the forward primer:
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CCAAGGACCACCGA; and the reverse primer: GATC
CCGGACGAGCCCCCAAATGAAAGACCC. Rec5.5m-L
was constructed by mutagenesis of Rec5-L using the for-
ward primer: TCTTGCTGTTGCATCCGACTTGTGGT
CTCGCTGTT; and the reverse primer: AGTCGGAT
GCAACAGCAAGAGGCTTTATTG. Rec5.567m-L was
constructed by mutagenesis of Rec5.5m-L using the for-
ward primer: GGAGACCCTTGCCCAGGGACCACCG
ACC; and the reverse primer: AAGGGTCTCCGGAT
CCCGGACGAGCCC. Structures of the expression vectors
were confirmed by digestion with restriction enzymes and
sequence analysis. Basic recombinant DNA procedures
were performed according to standard protocols [47].
Cell culture
NIH3T3 cells were grown in Dulbecco’s Modified Eagle
Medium – low glucose (SIGMA) supplemented with
10% fetal calf serum (MP Biomedicals) and penicillin-
streptomycin (GIBCO) and cells were incubated at 37°C
in a 7% CO2 atmosphere. HeLa cells were grown under
the same conditions as NIH3T3 except they were incu-
bated in a 5% CO2 atmosphere.
Transfection and assay for luciferase activity
NIH3T3 cells (1 × 105) were plated in 24-well plates with
growth medium minus penicillin and transfected the
next day with 0.8 ug luciferase expression vectors, 5 ng
of pRL-SV40 (Promega) using 2 ul of Lipofectamine
2000 Reagent (Invitrogen, Carlsbad, CA, USA) diluted
with OPTI-MEM (Invitrogen). After 48 hours, cells were
lysed and luciferase activities were measured as Relative
Light Units (RLU) using a luminometer with a Dual-
Luciferase Reporter Assay System (Promega) according
to the manufacturer’s instructions. The luciferase acti-
vity of each sample was normalized to that of Renilla
(pRL-SV40) as an internal control.
RNA extraction and quantification
RNA extraction was carried out using an RNase Mini
Kit (Qiagen). RNA was treated with RNase-free DNase
(Qiagen) and 2 ug of RNA were reverse transcribed
using an OligodT20 primer and SSIII reverse transcribing
kit (Invitrogen). A portion of the resulting cDNA was
subjected to real-time PCR using an Applied BiosystemsW
7500 Real-Time PCR System. The specific primers and
probes used for detection of total mRNA at the luc region
were: LucF: CGGCTTCGGCATGTTCA; LucR: TACAT
GAGCACGACCCGAAA: TaqMan probe: CACGCTG
GGCTACTTGATCTGCGG. Spliced-mRNA was detected
using s6: GGGTCTTT CATTTGGGGGCTC; s2: TGC
CGCCAACGGTCTCC and the TaqMan probe: CA
CCACCGGGAGCTCATTTACAGGCAC. Standard curves
to quantify both mRNAs derived from the luciferaseexpression vectors utilized vector splA8L [46]. In addition,
gapdh-mRNA was quantified as an internal control using
TaqMan Rodent GAPDH Control Reagents containing pri-
mer sets and probes (Applied Biosystems). Standard curves
to calculate the amount of mRNA were created using seri-
ally diluted gapdh T-easy vector. The negative control sam-
ples without the cDNA synthesis step showed undetectable
amplification.
Genomic DNA extraction and quantification
Cellular genomic DNA (gDNA) was extracted using a
DNeasy Blood and Tissue Kit (Qiagen) according to
the manufacturer’s instructions. Real-time PCR was
performed to quantify the amount of plasmid DNAs
introduced into the cells. Primers and probe sets used to
quantify the amount of firefly luciferase expression
vector introduced were the same TaqMan primer and
probe set used to detect the amount of cDNA. The
amount of gapdh DNA was measured as an internal
control using the TaqMan Rodent GAPDH Control
Reagents.
Cell fractionation
Nuclear and cytoplasmic fractions were obtained from
cultured cells using a PARIS kit (Ambion) according to
the manufacturer’s manual. As a control for the
fractionation, an aliquot of total RNA from each section
was electrophoresed on a 1% agarose gel in morpholi-
nepropane-sulfonic acid (MOPS) buffer, and the cellular
ribosomal RNAs were visualized by ethidium-bromide
staining.
Determination of poly (A) tail length
Total RNA extracted from 24 hours post-transfected
Hela-cells were ligated with RV3PC–anchor primers.
Reverse transcription was then carried out using an
antisense sequence of the RV3PC-anchor primer. To
amplify the poly (A) tail of mRNA, a forward primer
targeting the 3’end of U3 at LTR (AGCTCACAA
CCCCTCACTCGGC) was paired with a reverse primer
targeting the RV3PC-anchor sequence. To increase the
likelihood of the reverse primer binding at the poly(A)
tail, ten thymines were added into the 3’end of the re-
verse primer sequence (CTAGCAAAATAGGCTGTCC
CTTTTTTTTTT). Likewise, to detect the poly (A)
tail length of the gapdh-mRNA, a forward primer,
Mgapdh3end (CCCTACTCTCTTGAATACCATCA), was
set at the junction before the poly(A) signal and was used
with the same reverse primer targeting the RV3PC-anchor
sequence. The resulting PCR products were stained in
ethidium bromide and electrophoresed on an 8% polyacry-
lamide gel to visualize the spliced mRNA. A 3% agarose gel
was used to visualize gapdh-mRNA. Within the pool of
reverse-transcribed cDNA, the following primers were used
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f-597 (GGGCTCGTCCGGGATC) and reverse primer s2
(TGCCGCCAACGGTCTCC); for gapdh-mRNA, the for-
ward and reverse primers from the Taqman Rodent
GAPDH control reagents (Applied Biosystems) were used.Competing interests
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